- delivers a safe and clear environment for compounding of harmful drug preparations in compliance with USP and criteria. It can be suited to work involving harmful products, antineoplastic, or cytotoxic compounding programs. Electronic file-holding programs should be validated to be certain they meet these needs and they are secure from una